These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 20859196

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
    Lim A, Sia S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1431-8. PubMed ID: 21640504
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
    Stock RG, Chen AS, Karasek K.
    Cancer J Sci Am; 1996 Mar 15; 2(5):256-62. PubMed ID: 9166542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Para-aortic involvement and interest of para-aortic lymphadenectomy after chemoradiation therapy in patients with stage IB2 and II cervical carcinoma radiologically confined to the pelvic cavity.
    Delpech Y, Haie-Meder C, Rey A, Zafrani Y, Uzan C, Gouy S, Pautier P, Lhommé C, Duvillard P, Castaigne D, Morice P.
    Ann Surg Oncol; 2007 Nov 15; 14(11):3223-31. PubMed ID: 17713822
    [Abstract] [Full Text] [Related]

  • 8. Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.
    Farley JH, Hickey KW, Carlson JW, Rose GS, Kost ER, Harrison TA.
    Cancer; 2003 May 01; 97(9):2196-202. PubMed ID: 12712471
    [Abstract] [Full Text] [Related]

  • 9. Negative prognostic impact of the coexpression of epidermal growth factor receptor and c-erbB-2 in locally advanced cervical cancer.
    Pérez-Regadera J, Sánchez-Muñoz A, De-la-Cruz J, Ballestín C, Lora D, García-Martín R, Mendiola C, Alonso L, Alba E, Lanzós E.
    Oncology; 2009 May 01; 76(2):133-41. PubMed ID: 19174612
    [Abstract] [Full Text] [Related]

  • 10. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
    Schefter T, Winter K, Kwon JS, Stuhr K, Balaraj K, Yaremko BP, Small W, Sause W, Gaffney D, Radiation Therapy Oncology Group (RTOG).
    Int J Radiat Oncol Biol Phys; 2014 Jan 01; 88(1):101-5. PubMed ID: 24331655
    [Abstract] [Full Text] [Related]

  • 11. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
    Okazawa M, Mabuchi S, Isohashi F, Suzuki O, Yoshioka Y, Sasano T, Ohta Y, Kamiura S, Ogawa K, Kimura T.
    Int J Gynecol Cancer; 2013 Mar 01; 23(3):567-75. PubMed ID: 23385284
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cervical cancer: combined modality therapy.
    Grigsby PW.
    Cancer J; 2001 Mar 01; 7 Suppl 1():S47-50. PubMed ID: 11504285
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Extended field radiation and cisplatin for stage IIB and IIIB cervical carcinoma.
    Malfetano JH, Keys H, Cunningham MJ, Gibbons S, Ambros R.
    Gynecol Oncol; 1997 Nov 01; 67(2):203-7. PubMed ID: 9367709
    [Abstract] [Full Text] [Related]

  • 18. Clinical outcomes of definitive chemoradiation followed by intracavitary pulsed-dose rate image-guided adaptive brachytherapy in locally advanced cervical cancer.
    Castelnau-Marchand P, Chargari C, Maroun P, Dumas I, Del Campo ER, Cao K, Petit C, Martinetti F, Tafo-Guemnie A, Lefkopoulos D, Morice P, Haie-Meder C, Mazeron R.
    Gynecol Oncol; 2015 Nov 01; 139(2):288-94. PubMed ID: 26364808
    [Abstract] [Full Text] [Related]

  • 19. Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.
    Lee CM, Lee RJ, Hammond E, Tsodikov A, Dodson M, Zempolich K, Gaffney DK.
    Gynecol Oncol; 2004 Apr 01; 93(1):209-14. PubMed ID: 15047238
    [Abstract] [Full Text] [Related]

  • 20. Role of Surgical Versus Clinical Staging in Chemoradiated FIGO Stage IIB-IVA Cervical Cancer Patients-Acute Toxicity and Treatment Quality of the Uterus-11 Multicenter Phase III Intergroup Trial of the German Radiation Oncology Group and the Gynecologic Cancer Group.
    Marnitz S, Martus P, Köhler C, Stromberger C, Asse E, Mallmann P, Schmidberger H, Affonso Júnior RJ, Nunes JS, Sehouli J, Budach V.
    Int J Radiat Oncol Biol Phys; 2016 Feb 01; 94(2):243-53. PubMed ID: 26853333
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.